JP2023552864A5 - - Google Patents

Info

Publication number
JP2023552864A5
JP2023552864A5 JP2023535832A JP2023535832A JP2023552864A5 JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5 JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5
Authority
JP
Japan
Prior art keywords
methyl
formula
pyridazin
imidazo
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023535832A
Other languages
English (en)
Japanese (ja)
Other versions
JP7827725B2 (ja
JP2023552864A (ja
Filing date
Publication date
Priority claimed from GBGB2019702.6A external-priority patent/GB202019702D0/en
Priority claimed from GBGB2109583.1A external-priority patent/GB202109583D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/084448 external-priority patent/WO2022128584A1/en
Publication of JP2023552864A publication Critical patent/JP2023552864A/ja
Publication of JP2023552864A5 publication Critical patent/JP2023552864A5/ja
Application granted granted Critical
Publication of JP7827725B2 publication Critical patent/JP7827725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023535832A 2020-12-14 2021-12-06 Il-17モジュレータとしてのイミダゾピリダジン誘導体 Active JP7827725B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2019702.6 2020-12-14
GBGB2019702.6A GB202019702D0 (en) 2020-12-14 2020-12-14 Therapeutic agents
GBGB2109583.1A GB202109583D0 (en) 2021-07-02 2021-07-02 Therapeutic agents
GB2109583.1 2021-07-02
PCT/EP2021/084448 WO2022128584A1 (en) 2020-12-14 2021-12-06 Imidazopyridazine derivatives as il-17 modulators

Publications (3)

Publication Number Publication Date
JP2023552864A JP2023552864A (ja) 2023-12-19
JP2023552864A5 true JP2023552864A5 (cg-RX-API-DMAC7.html) 2024-11-15
JP7827725B2 JP7827725B2 (ja) 2026-03-10

Family

ID=79164779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535832A Active JP7827725B2 (ja) 2020-12-14 2021-12-06 Il-17モジュレータとしてのイミダゾピリダジン誘導体

Country Status (5)

Country Link
US (1) US20240140951A1 (cg-RX-API-DMAC7.html)
EP (1) EP4259631A1 (cg-RX-API-DMAC7.html)
JP (1) JP7827725B2 (cg-RX-API-DMAC7.html)
CA (1) CA3200594A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022128584A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
US20240140951A1 (en) * 2020-12-14 2024-05-02 UCB Biopharma SRL Imidazopyridazine derivatives as il-17 modulators
AR126255A1 (es) 2021-07-01 2023-10-04 UCB Biopharma SRL Derivados de imidazotriazina como moduladores de il-17
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
WO2023111181A1 (en) 2021-12-16 2023-06-22 Leo Pharma A/S Small molecule modulators of il-17
EP4486737A1 (en) 2022-03-04 2025-01-08 LEO Pharma A/S Small molecule modulators of il-17
GB202210731D0 (en) 2022-07-22 2022-09-07 UCB Biopharma SRL Therapeutic agents
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024138286A1 (en) * 2022-12-26 2024-07-04 Usynova Pharmaceuticals, Ltd. Il-17a modulators
CN121487927A (zh) * 2023-03-14 2026-02-06 歌礼制药(中国)有限公司 Il-17a的小分子调节剂、制备方法及其使用方法
EP4688156A1 (en) * 2023-03-28 2026-02-11 Janssen Pharmaceutica NV Lactam-containing imidazopyridazine il-17 inhibitor compounds
CN122580300A (zh) 2024-01-11 2026-08-14 浙江海正药业股份有限公司 磺酰胺类衍生物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2711696C (en) 2008-01-09 2021-10-26 Reza Dana Therapeutic compositions for treatment of ocular inflammatory disorders
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
WO2014066726A2 (en) 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
CN111601799B (zh) 2018-01-15 2023-06-09 Ucb生物制药有限责任公司 作为Il-17调节剂的稠合咪唑衍生物
WO2019223718A1 (zh) 2018-05-22 2019-11-28 成都先导药物开发股份有限公司 一种免疫调节剂
WO2020011731A1 (en) 2018-07-12 2020-01-16 UCB Biopharma SRL Spirocyclic indane analogues as il-17 modulators
GB201820165D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
MX2021006421A (es) 2018-12-19 2021-08-16 Leo Pharma As Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
TWI752400B (zh) 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
EP3935051A1 (en) 2019-03-08 2022-01-12 Leo Pharma A/S Small molecule modulators of il-17
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909194D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909191D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
KR20230017211A (ko) 2020-04-30 2023-02-03 얀센 파마슈티카 엔.브이. Il-17 경로의 조절인자를 식별하는 방법
JP7664947B2 (ja) 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン
US20240140951A1 (en) * 2020-12-14 2024-05-02 UCB Biopharma SRL Imidazopyridazine derivatives as il-17 modulators

Similar Documents

Publication Publication Date Title
JP2024525044A5 (cg-RX-API-DMAC7.html)
CN101228169B (zh) 丙型肝炎病毒的大环抑制剂
CN111278815B (zh) 戊二酰亚胺
US10954247B2 (en) Apelin receptor (APJ) agonists and uses thereof
US11572374B2 (en) N-cyano-7-azanorbornane derivatives and uses thereof
AU2017343638B2 (en) Heterocyclic apelin receptor (APJ) agonists and uses thereof
TWI297011B (en) Dpp-iv inhibitors
RU2339636C2 (ru) Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv)
EP2822942B1 (en) Benzodioxanes for inhibiting leukotriene production
JP4068958B2 (ja) 免疫抑制剤としてのピロロ(2,3−d)ピリミジン化合物
EP2590981B1 (en) Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
JP2008510006A5 (cg-RX-API-DMAC7.html)
CN106661017B (zh) 二环性或三环性杂环化合物
PT1912997E (pt) Inibidores macrocíclicos do vírus da hepatite c
RU2002104935A (ru) ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА
JP2021523941A5 (cg-RX-API-DMAC7.html)
US12590099B2 (en) Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
JP5384733B2 (ja) 6,7−ジヒドロ−5H−イミダゾ[1,2−a]イミダゾール−3−カルボン酸アミドの誘導体
JP5389917B2 (ja) ケモカインレセプターのジアゼパン及びピペラジン誘導体モデュレーター
KR101238281B1 (ko) 효과적인 진통제로서의 (1s,5s)-3-(5,6-디클로로-3-피리디닐)-3,6-디아자비사이클로[3.2.0]헵탄
JP2007512317A (ja) ピラゾロピリミジン類
JP2007532526A (ja) ピラゾロ[4,3−d]ピリミジン類
MX2008001404A (en) Macrocyclic inhibitors of hepatitis c virus